These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4140854)

  • 1. Clinical significance of increased serum myoinositol levels.
    Melmed S; Bank H; Lewin LM
    Isr J Med Sci; 1974 Dec; 10(12):1518-22. PubMed ID: 4140854
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of renal function from the blood urea and serum creatinine concentrations.
    Wing AJ
    East Afr Med J; 1969 May; 46(5):329-33. PubMed ID: 5345971
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical indications for clearance determination].
    Reubi F
    Praxis; 1967 Jun; 56(23):805-6. PubMed ID: 5632968
    [No Abstract]   [Full Text] [Related]  

  • 4. Anemia in uremia. Hemolysis evaluated by common methods and application of the bilirubin turnover method.
    Eklund SG; Johansson SV; Strandberg O
    Acta Med Scand; 1971 Nov; 190(5):435-43. PubMed ID: 5149271
    [No Abstract]   [Full Text] [Related]  

  • 5. Raised plasma-myoinositol levels in uraemia and experimental neuropathy.
    Clements RS; DeJesus PV; Winegrad AI
    Lancet; 1973 May; 1(7813):1137-41. PubMed ID: 4123536
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum magnesium in renal diseases.
    Chatterjea MN; Saran A
    J Indian Med Assoc; 1974 Nov; 63(10):311-5. PubMed ID: 4452784
    [No Abstract]   [Full Text] [Related]  

  • 7. [Simple method of quantitative determination of myoinositol in the serum and urine].
    Lutz W; Trznadel K; Walasek L
    Pol Tyg Lek; 1976 May; 31(17):711-3. PubMed ID: 934940
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnostic value of determining middle molecules in the blood plasma in nephrological diseases].
    Gabriélian NI; Dmitriev AA; Kulakov GP; Melikian AM; Shcherbaneva OI
    Klin Med (Mosk); 1981 Oct; 59(10):38-42. PubMed ID: 7311409
    [No Abstract]   [Full Text] [Related]  

  • 9. Some observations on serum magnesium in renal disease.
    Jain MC; Singh D
    J Indian Med Assoc; 1969 May; 52(9):409-13. PubMed ID: 5798954
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical studies on the question of toxicity of prolonged administration of cyclamate in patients with liver and kidney diseases].
    Zöllner N; Schnelle K
    Arzneimittelforschung; 1967 Dec; 17(12):1568-73. PubMed ID: 5632800
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of BUN and non-protein nitrogen analysis in clinical tests].
    Orita Y; Kakihara M; Kamada T
    Nihon Rinsho; 1989 Dec; 48 Suppl():417-20. PubMed ID: 2621914
    [No Abstract]   [Full Text] [Related]  

  • 12. Myoinositol--a uremic neurotoxin?
    Blumberg A; Esslen E; Bürgi W
    Nephron; 1978; 21(4):186-91. PubMed ID: 683404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentre trial with cephacetrile in the treatment of severe infections.
    Corrêa Lima MB; Louro E; Netto AR; Borges da Cunha A; Polisuk J; Mangabeira Albernaz PL; Bethlem N; da Rosa Santos O; Freire de Sequeira O; Aguinaga S; Coelho Gomes S
    Arzneimittelforschung; 1974 Sep; 24(9b):1515-23. PubMed ID: 4479817
    [No Abstract]   [Full Text] [Related]  

  • 14. Indication of intrinsic renal disease in azotemic infants with diarrhea and dehydration.
    Brill CB; Uretsky S; Gribetz D
    Pediatrics; 1973 Aug; 52(2):197-205. PubMed ID: 4721442
    [No Abstract]   [Full Text] [Related]  

  • 15. A one-day test for measuring renal function.
    McKean WI; Dixon SR; Braidwood JL; Irvine RO
    N Z Med J; 1969 Jun; 69(445):337-41. PubMed ID: 5257550
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical therapeutic experiences with vibramycin in the treatment of urinary tract infections].
    Vetter D; Reutter FW
    Ther Umsch; 1970 May; 27(5):331-6. PubMed ID: 5510329
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma fibrinolytic activity in chronic renal disorders.
    Gupta BK; Govil MK; Chandra J; Pandey JD
    J Indian Med Assoc; 1971 Nov; 57(9):324-6. PubMed ID: 4947639
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for kidney and urinary tract disease.
    Schlegel JU
    Proc Annu Meet Med Sect Am Life Conv; 1970 Jun; 58():23-34. PubMed ID: 5537292
    [No Abstract]   [Full Text] [Related]  

  • 19. [Change of blood platelet activity in patients with chronic uremia].
    Cordonnier D; Kolodie L; Hollard D; Muller JM
    J Urol Nephrol (Paris); 1969; 75(4):289-301. PubMed ID: 5370827
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action of propaxoline on hemodynamics and renal function in normal and pathological conditions].
    Mioli V; Albertazzi A; Vangelista A; Bonomini V
    Clin Ter; 1969 Sep; 50(5):437-64. PubMed ID: 5382526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.